— Know what they know.
Not Investment Advice

SYDRF OTC

Delota Corp.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +25.0% 3Y: -48.7%
$0.10
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Sell · Power 39 · $2.9M mcap · 26M float · 0.0033% daily turnover · Short 100% of daily vol

Income Trends

Revenue
$35M -13.2% ▼
5Y CAGR: +93.8%
Gross Profit
$4M -77.5% ▼
5Y CAGR: +55.7%
Operating Income
-$519K -207.7% ▼
Net Income
-$746K -232.7% ▼
EPS (Diluted)
$-0.03 -233.2% ▼
EBITDA
$1M -71.0% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
Revenue$18M$26M$34M$40M$35M
YoY Growth+1285.9%+46.7%+31.4%+18.0%-13.2%
Cost of Revenue$10M$14M$20M$25M$31M
Gross Profit$8M$12M$14M$16M$4M
Gross Margin44.2%47.1%40.0%39.0%10.1%
R&D Expenses$0$0$0$0$0
SG&A Expenses$7M$10M$11M$13M$4M
Operating Expenses$9M$12M$14M$15M$4M
Operating Income-$29K$2M$2M$482K-$519K
Operating Margin-0.2%7.6%5.1%1.2%-1.5%
Interest Expense$812K$914K$1M$1M$825K
Income Before Tax-$9M$8M-$2M$498K-$810K
Tax Expense-$53K-$64K-$64K-$64K-$64K
Net Income-$9M$8M-$2M$562K-$746K
Net Margin-50.0%29.6%-5.8%1.4%-2.1%
EPS (Diluted)$-0.65$0.27$-0.07$0.02$-0.03
EBITDA-$7M$10M$823K$4M$1M
Shares Outstanding14M29M27M29M29M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms